SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs1613662 | chr19:55025227 (GRCh38.p7) | G>A | cocaine dependence | SNV(Single Nucleotide Variation) |
rs2304167 | chr19:55015713 (GRCh38.p7) | C>T | cocaine dependence | SNV(Single Nucleotide Variation) |
rs1654413 | chr19:55014991 (GRCh38.p7) | A>T | cocaine dependence | SNV(Single Nucleotide Variation) |
rs1671152 | chr19:55014977 (GRCh38.p7) | T>G | cocaine dependence | SNV(Single Nucleotide Variation) |
rs1671151 | chr19:55014526 (GRCh38.p7) | G>A | cocaine dependence | SNV(Single Nucleotide Variation) |
rs1671150 | chr19:55014129 (GRCh38.p7) | A>G | cocaine dependence | SNV(Single Nucleotide Variation) |
Probe | Locus(GRCh37) | Gene | Region | p-val | Trait | PubMed ID |
cg25818583 | chr19:55549801 | GP6 | 4.000e-9 | Smoking | 27651444 | |
cg02462353 | chr19:55549799 | GP6 | 2.900e-8 | Smoking | 27651444 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
ZFR2 | 0.756 |
ITGA2B | 0.743 |
MYO15A | 0.741 |
RABL2A | 0.739 |
SRRM3 | 0.739 |
BRICD5 | 0.737 |
PTCH2 | 0.735 |
VTN | 0.728 |
SLC26A10 | 0.727 |
PKD1 | 0.724 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
YES1 | -0.408 |
SLC40A1 | -0.396 |
ASB4 | -0.374 |
TFPI2 | -0.37 |
C9orf135 | -0.369 |
REST | -0.369 |
PHEX | -0.368 |
CDCA7L | -0.362 |
PABPC4L | -0.359 |
NXT2 | -0.358 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D001241 | Aspirin | GP6 gene polymorphism results in decreased susceptibility to Aspirin | 16493486 |
C006780 | bisphenol A | bisphenol A results in decreased expression of GP6 mRNA | 25181051 |
D002104 | Cadmium | Cadmium results in decreased expression of GP6 mRNA | 24376830 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of GP6 mRNA | 25016146 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GP6 mRNA | 25613284 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GP6 mRNA | 25613284 |
D014810 | Vitamin E | Vitamin E results in decreased expression of GP6 mRNA | 19244175 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004888 | transmembrane signaling receptor activity | - | TAS | 10822077 |
GO:0005515 | protein binding | - | IPI | 1715582 19940238 |
GO:0005518 | collagen binding | - | TAS | 11027634 |
GO:0038023 | signaling receptor activity | - | TAS | 11027634 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007167 | enzyme linked receptor protein signaling pathway | - | TAS | 9153205 |
GO:0007596 | blood coagulation | - | TAS | - |
GO:0030168 | platelet activation | - | NAS | 11027634 |
GO:0030168 | platelet activation | - | TAS | - |
GO:0050900 | leukocyte migration | - | TAS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | TAS | 10822077 |
GO:0009986 | cell surface | - | HDA | 23382103 |
GO:0070062 | extracellular exosome | - | HDA | 23533145 |
GO:0097197 | tetraspanin-enriched microdomain | - | IDA | 18795891 |
KEGG ID | KEGG Term |
---|---|
hsa04512 | ECM-receptor interaction |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109582 | Hemostasis | TAS |
R-HSA-114604 | GPVI-mediated activation cascade | TAS |
R-HSA-202733 | Cell surface interactions at the vascular wall | TAS |
R-HSA-75892 | Platelet Adhesion to exposed collagen | TAS |
R-HSA-76002 | Platelet activation, signaling and aggregation | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
25147721 | Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma. (2014 May) | Mirzaie-Kashani E | Jundishapur J Microbiol |
16129653 | Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. (2005 Nov) | Campisi G | Oral Oncol |
20695077 | Human papillomavirus as an independent predictor in oral squamous cell cancer. (2009 Sep) | Zhao D | Int J Oral Sci |
19654578 | Differences in the risk of cervical cancer and human papillomavirus infection by education level. (2009 Sep 1) | Franceschi S | Br J Cancer |
16476033 | H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia. (2006 Mar) | Piscopo M | Oral Dis |
15583544 | HPV DNA in clinically different variants of oral leukoplakia and lichen planus. (2004 Dec) | Campisi G | Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
15288840 | Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection. (2004 Sep) | Campisi G | Oral Oncol |
15729691 | Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma: use of fuzzy neural networks. (2005 Jul 10) | Lo Muzio L | Int J Cancer |
18164962 | High association of human papillomavirus infection with oral cancer: a case-control study. (2008 Feb) | Anaya-Saavedra G | Arch Med Res |